Resources » Desmopressin (DDAVP)
LINKS
DETAILS

Year: 2016

Language: English

This resource is also available in: Arabic French Russian Spanish Chinese (Simplified)

Author(s): World Federation of Hemophilia

Format: Document

Desmopressin (DDAVP)

ADDITIONAL INFORMATION

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish


Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than plasma products or recombinant clotting factor concentrates, carries no risk of transmission of viral infections, and is on the World Health Organization’s (WHO) Model List of Essential Medicines (EML).

RELATED RESOURCES